Skip to content

13F-HR/A filed by Birchview Capital, LP

Birchview Capital, LP filed this 13F-HR/A for the quarter ended 2014-12-31, filed 2015-05-07, with 33 holding rows worth $172,249,000.

Accession
0001618205-15-000002
Filed
2015-05-07
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2014

A holdings report, amendment of type restatement, 33 entries on the cover page, a total value of $172,249,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $172,249,000 with VALUE read as thousands by filing date, 13F file number 028-16416. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CELGENE CORP151020104COM813,911$91,044,000thousands by filing date
Accelerate Diagnostics00430H102COM2,065,560$39,638,000thousands by filing date
VERMILLION INC92407M206COM NEW2,717,514$5,270,000thousands by filing date
METABOLIX INC591018809COM12,705,000$5,065,000thousands by filing date
EQT CORP COM26884L109Stock41,300$3,126,000thousands by filing date
BIOLASE INC090911108COMMON STOCK1,185,903$3,119,000thousands by filing date
SOUTHWESTERN ENERGY CO845467109COM96,483$2,633,000thousands by filing date
MEDIVATION INC58501N101COM21,680$2,160,000thousands by filing date
Gilead Sciences,Inc.375558103COM18,670$1,760,000thousands by filing date
HANSEN MEDICAL INC411307101COM2,920,928$1,623,000thousands by filing date
AUSPEX PHARMACE05211J102Common Stock25,500$1,338,000thousands by filing date
CONTINENTAL RES INC212015101COM32,674$1,253,000thousands by filing date
TORNIER NVN87237108COMMON STOCK-FO49,000$1,250,000thousands by filing date
QUIDEL CORP74838J101COM38,975$1,127,000thousands by filing date
ACCURAY INC DEL004397105COM143,300$1,082,000thousands by filing date
Transition Therapeutics, Inc.893716209COM150,746$1,031,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM19,900$1,030,000thousands by filing date
ENCANA CORP292505104COM69,700$967,000thousands by filing date
MASIMO CORP COM574795100Stock36,600$964,000thousands by filing date
Merck & Co.,Inc.58933Y105COM15,000$852,000thousands by filing date
QUOTIENT LTDG73268107SHS39,710$715,000thousands by filing date
CELGENE CORP151020112RIGHT 12/31/2030213,432$672,000thousands by filing date
COTERRA ENERGY INC COM127097103Stock21,000$622,000thousands by filing date
ONCOMED PHARMACEUTICALS INC COM68234X102Stock22,489$489,000thousands by filing date
MERRIMACK PHARMACEUTICALS IN590328100COM42,300$478,000thousands by filing date
BIOGEN INC COM09062X103Stock1,400$475,000thousands by filing date
PETROQUEST ENERGY INC716748108COMMON STOCK122,050$456,000thousands by filing date
PIONEER NATURAL RESOURCES CO723787107COM3,000$447,000thousands by filing date
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK2,150$407,000thousands by filing date
AGIOS PHARMACEUTICALS INC00847X104COM3,400$381,000thousands by filing date
ROKA BIOSCIENCE INC775431109COM85,900$379,000thousands by filing date
NXSTAGE MEDICAL INC67072V103COMMON STOCK14,700$264,000thousands by filing date
INSPIREMD INC45779A309COM170,000$132,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001618205-15-000001 superseded2015-02-06acceptance time not in the bulk data set
13F-HR/A 0001603544-15-000003 superseded2015-04-24acceptance time not in the bulk data set
13F-HR/A 0001618205-15-000002this filing2015-05-07acceptance time not in the bulk data set